Clinics in Liver Disease

Papers
(The TQCC of Clinics in Liver Disease is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Navigating the Management of Hepatocellular Carcinoma324
Chronic Hepatitis B Virus in Patients with Chronic Hepatitis C Virus47
Forthcoming Issues37
Copyright30
Contributors30
Contributors29
Hepatitis B and Health Care Workers28
Forthcoming Issues27
Forthcoming Issues26
Recurrent and De Novo Liver Disease After Liver Transplantation24
Forthcoming Issues23
The Role of Liver Transplantation in Hepatocellular Carcinoma22
Contributors21
Artificial Intelligence and Machine Learning Applications in Liver Disease20
The Changing Demographics of Hepatitis B Virus Infection20
Controversies in the Management of Hepatitis B19
Forthcoming Issues18
Endoscopic Ultrasound-Guided Liver Biopsy17
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment16
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination16
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease16
Overview of New Targets for Hepatitis B Virus15
Controversies in Treating Chronic HBV15
What is the Path Forward to Treat Hepatitis Delta Virus?15
Contents15
Through the Scope Hepatobiliary Interventions in Patients with Liver Diseases: Minimizing Risks and Improving Outcomes15
Management of Biliary Complications in Liver Transplant Recipients14
Preface14
Pathogenesis of Alcohol-Associated Liver Disease13
Primary Biliary Cholangitis13
Preface13
Evaluation and Management of Pruritus in Primary Biliary Cholangitis12
Consultations in Liver Disease12
Nonalcoholic Fatty Liver Disease in Latin America and Australia12
Contributors11
Portal Hypertension and its Complications11
Alcohol-Associated Liver Disease11
The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients11
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings10
Primary Sclerosing Cholangitis10
Targeting Hepatitis B Virus DNA Using Designer Gene Editors9
Contents9
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease9
Biliary Atresia in Children8
The Liver in Hematologic Malignancies8
Hepatocellular Carcinoma8
Hepatorenal Syndrome8
Minimal Hepatic Encephalopathy8
Pharmacologic Management of Hepatic Encephalopathy8
The Liver in Diabetes and Metabolic Syndrome8
Current and Next-Generation Therapeutics in Hepatology8
Copyright8
Recent Advances in Primary Biliary Cholangitis Treatment8
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis8
Beyond the Liver8
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats8
Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases8
Prognostic Scoring Systems in Primary Biliary Cholangitis7
Hepatitis B and C in Children7
Controversies in Treating Chronic Hepatitis B virus7
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape7
Forthcoming Issues7
Alcohol Use Disorder7
Improving Diagnostic Yield in Indeterminate Biliary Strictures7
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease7
Navigating Hepatocellular Carcinoma7
Forthcoming Issues7
Copyright7
Treatment of Primary Sclerosing Cholangitis Including Transplantation7
Novel Therapies in Primary Biliary Cholangitis7
Preventing Readmissions for Hepatic Encephalopathy7
Acute Alcoholic Hepatitis7
Disease Modulating Agents in Cirrhosis6
Use of Hepatitis B Virus–Positive Organs in Organ Transplantation6
Contents6
Amyloidosis and the Liver6
Genetics of Primary Biliary Cholangitis6
Chronic Hepatitis B6
Primary Biliary Cholangitis6
Contents6
Kidney Allocation Issues in Liver Transplantation Candidates with Chronic Kidney Disease and Severe Kidney Liver Injury6
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis6
Preface6
Overview of Progressive Familial Intrahepatic Cholestasis6
Alagille Syndrome6
The Evolving Role of Therapeutic Endoscopy in Patients with Chronic Liver Diseases6
Hepatic Encephalopathy6
0.10853385925293